Brain wave study tests drugs for genetic disorder
NCT ID NCT05418049
Summary
This study is testing single doses of three existing medications—baclofen, roflumilast, and memantine—to see if they can improve brain activity and behavior in adults with Fragile X Syndrome. Researchers will measure changes in brain waves and ask caregivers about symptoms after participants take one dose. The goal is to see if any of these drugs might help control the challenges of this genetic condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRAGILE X SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
Conditions
Explore the condition pages connected to this study.